The Environmental Genome Project: Reference Polymorphisms for Drug Metabolism Genes and Genome-Wide Association Studies

REFERENCES

• Barrett J. C., Cardon L. R. Evaluating coverage of genome-wide association studies. Nat. Genet. 2006; 6: 659–662
   Web of Science ®Google Scholar
• Bhangale T. R., Stephens M., Nickerson D. A. Automating resequencing-based detection of insertion-deletion polymorphisms. Nat. Genet. 2006; 12: 1457–1462
   Web of Science ®Google Scholar
• Bosch T. M., Meijerman I., Beijnen J. H., Schellens J. H. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin. Pharmacokinet. 2006; 3: 253–285
   Web of Science ®Google Scholar
• Carlson C. S., Eberle M. A., Rieder M. J., Smith J. D., Kruglyak L., Nickerson D. A. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat. Genet. 2003; 33: 518–521
   PubMed Web of Science ®Google Scholar
• Carlson C. S., Eberle M. A., Rieder M. J., Yi Q., Kruglyak L., Nickerson D. A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 2004; 1: 106–120
   Web of Science ®Google Scholar
• Chanock S. J., Manolio T., Boehnke M., Boerwinkle E., Hunter D. J., Thomas G., et al. Replicating genotype-phenotype associations. Nature 2007; 7145: 655–660
   Web of Science ®Google Scholar
• Chowbay B., Zhou S., Lee E. J. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab. Rev. 2005; 2: 327–378
   Google Scholar
• Clark A. G., Hubisz M. J., Bustamante C. D., Williamson S. H., Nielsen R. Ascertainment bias in studies of human genome-wide polymorphism. Genome Res. 2005; 11: 1496–1502
   Web of Science ®Google Scholar
• Collins F. S., Brooks L. D., Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 1998; 12: 1229–1231
   Google Scholar
• Conrad D. F., Jakobsson M., Coop G., Wen X., Wall J. D., Rosenberg N. A., et al. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat. Genet 2006; 11: 1251–1260
   Web of Science ®Google Scholar
• Daly A. K. Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet. 2006; 1: 13–31
   Web of Science ®Google Scholar
• de Bakker P. I., Burtt N. P., Graham R. R., Guiducci C., Yelensky R., Drake J. A., et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nat. Genet. 2006; 11: 1298–1303
   Web of Science ®Google Scholar
• de Bakker P. I., Yelensky R., Pe'er I., Gabriel S. B., Daly M. J., Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005; 11: 1217–1223
   Web of Science ®Google Scholar
• Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 5804: 1461–1463
   Web of Science ®Google Scholar
• Easton D. F., Pooley K. A., Dunning A. M., Pharoah P. D., Thompson D., Ballinger D. G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 7148: 1087–1093
   Web of Science ®Google Scholar
• Eichler E. E., Nickerson D. A., Altshuler D., Bowcock A. M., Brooks L. D., Carter N. P., et al. Completing the map of human genetic variation. Nature 2007; 7141: 161–165
   Web of Science ®Google Scholar
• Ekins S., Wrighton S. A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 1999; 3: 719–754
   Web of Science ®Google Scholar
• Evans W. E., Relling M. V. Moving towards individualized medicine with pharmacogenomics. Nature 2004; 6990: 464–468
   Web of Science ®Google Scholar
• Fan J. B., Chee M. S., Gunderson K. L. Highly parallel genomic assays. Nat. Rev. Genet. 2006; 8: 632–644
   Web of Science ®Google Scholar
• Field S. F., Howson J. M., Smyth D. J., Walker N. M., Dunger D. B., Todd J. A. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 2007; 1: 212–213
   Google Scholar
• Fodor S. P., Read J. L., Pirrung M. C., Stryer L., Lu A. T., Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 1991; 4995: 767–773
   Web of Science ®Google Scholar
• Goldstein D. B., Tate S. K., Sisodiya S. M. Pharmacogenetics goes genomic. Nat. Rev. Genet. 2003; 12: 937–947
   Web of Science ®Google Scholar
• Gonzalez J. R., Armengol L., Sole X., Guino E., Mercader J. M., Estivill X., et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 5: 644–645
   Google Scholar
• Gudmundsson J., Sulem P., Manolescu A., Amundadottir L. T., Gudbjartsson D., Helgason A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 2007; 5: 631–637
   Web of Science ®Google Scholar
• Gunderson K. L., Kuhn K. M., Steemers F. J., Ng P., Murray S. S., Shen R. Whole-genome genotyping of haplotype tag single nucleotide polymorphisms. Pharmacogenomics 2006a; 4: 641–648
   Web of Science ®Google Scholar
• Gunderson K. L., Steemers F. J., Ren H., Ng P., Zhou L., Tsan C., et al. Whole-genome genotyping. Meth. Enzymol. 2006b; 410: 359–376
   PubMed Web of Science ®Google Scholar
• Haines J. L., Hauser M. A., Schmidt S., Scott W. K., Olson L. M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 5720: 419–421
   Web of Science ®Google Scholar
• Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 5830: 1491–1493
   Web of Science ®Google Scholar
• Hodgson E., Rose R. L. The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals. Pharmacol. Ther. 2007; 2: 420–428
   Web of Science ®Google Scholar
• Ingelman-Sundberg M., Daly A. K., Oscarson M., Nebert D. W. Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles. Pharmacogenetics 2000; 1: 91–93
   Google Scholar
• Kruglyak L., Nickerson D. A. Variation is the spice of life. Nat. Genet 2001; 3: 234–236
   Web of Science ®Google Scholar
• Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 2001; 4: 383–391
   Web of Science ®Google Scholar
• Lamba J. K., Lin Y. S., Schuetz E. G., Thummel K. E. Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv.Rev. 2002; 10: 1271–1294
   Web of Science ®Google Scholar
• Lang T., Klein K., Fischer J., Nussler A. K., Neuhaus P., Hofmann U., et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 5: 399–415
   Google Scholar
• Lewis D. F. 57 varieties: the human cytochromes P450. Pharmacogenomics 2004, 3: 305–318
   PubMed Web of Science ®Google Scholar
• Lieber C. S. Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev. 1997; 2: 517–544
   Google Scholar
• Livingston R. J., von Niederhausern A., Jegga A. G., Crawford D. C., Carlson C. S., Rieder M. J., et al. Pattern of sequence variation across 213 environmental response genes. Genome Res. 2004; 10A: 1821–1831
   Web of Science ®Google Scholar
• Marchini J., Howie B., Myers S., McVean G., Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 2007; 7: 906–913
   Web of Science ®Google Scholar
• McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D. R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 5830: 1488–1491
   Web of Science ®Google Scholar
• Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr. Drug Metab. 2006; 1: 67–81
   Web of Science ®Google Scholar
• Nebert D. W., Dalton T. P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 2006; 12: 947–960
   Web of Science ®Google Scholar
• Nebert D. W., Dalton T. P., Okey A. B., Gonzalez F. J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004; 23: 23847–23850
   Web of Science ®Google Scholar
• Olden K., Wilson S. Environmental health and genomics: visions and implications. Nat. Rev. Genet. 2000; 2: 149–153
   Web of Science ®Google Scholar
• Pe'er I., Chretien Y. R., de Bakker P. I., Barrett J. C., Daly M. J., Altshuler D. M. Biases and reconciliation in estimates of linkage disequilibrium in the human genome. Am. J. Hum. Genet. 2006a; 4: 588–603
   Web of Science ®Google Scholar
• Pe'er I., de Bakker P. I., Maller J., Yelensky R., Altshuler D., Daly M. J. Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat. Genet. 2006b; 6: 663–667
   Web of Science ®Google Scholar
• Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M. A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 3: 559–575
   Web of Science ®Google Scholar
• Rioux J. D., Xavier R. J., Taylor K. D., Silverberg M. S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007; 5: 596–604
   Web of Science ®Google Scholar
• Rodriguez-Antona C., Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006; 11: 1679–1691
   Web of Science ®Google Scholar
• Roy J. N., Lajoie J., Zijenah L. S., Barama A., Poirier C., Ward B. J., et al. CYP3A5 genetic polymorphisms in different ethnic populations. Drug Metab. Dispos. 2005; 7: 884–887
   Web of Science ®Google Scholar
• Rushmore T. H., Kong A. N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002; 5: 481–490
   Web of Science ®Google Scholar
• Sadee W., Dai Z. Pharmacogenetics/genomics and personalized medicine. Hum. Mol. Genet. 2005; R207–214
   PubMed Web of Science ®Google Scholar
• Saxena R., Voight B. F., Lyssenko V., Burtt N. P., de Bakker P. I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 5829: 1331–1336
   Google Scholar
• Servin B., Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 2007; 7: e114
   Web of Science ®Google Scholar
• Shriver M. D., Mei R., Parra E. J., Sonpar V., Halder I., Tishkoff S. A., et al. Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics 2005; 2: 81–89
   PubMedGoogle Scholar
• Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 7130: 881–885
   Web of Science ®Google Scholar
• Solus J. F., Arietta B. J., Harris J. R., Sexton D. P., Steward J. Q., McMunn C., et al. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 2004; 7: 895–931
   Web of Science ®Google Scholar
• Stephens M., Sloan J. S., Robertson P. D., Scheet P., Nickerson D. A. Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat. Genet. 2006; 3: 375–381
   Web of Science ®Google Scholar
• Stranger B. E., Nica A. C., Forrest M. S., Dimas A., Bird C. P., Beazley C., et al. Population genomics of human gene expression. Nat Genet 2007; 39: 1217–1224
   PubMed Web of Science ®Google Scholar
• The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789–796
   PubMed Web of Science ®Google Scholar
• The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 693: 1299–1320
   Web of Science ®Google Scholar
• The Wellcome Trust Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–678
   PubMed Web of Science ®Google Scholar
• Thummel K. E., Wilkinson G. R. In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 389–430
   PubMed Web of Science ®Google Scholar
• Todd J. A., Walker N. M., Cooper J. D., Smyth D. J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007; 7: 857–864
   Web of Science ®Google Scholar
• Wilkinson G. R. Drug metabolism and variability among patients in drug response. N. Engl. J. Med. 2005; 21: 2211–2221
   Web of Science ®Google Scholar
• Xie H. G., Wood A. J., Kim R. B., Stein C. M., Wilkinson G. R. Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics 2004; 3: 243–272
   Web of Science ®Google Scholar
• Zeggini E., Rayner W., Morris A. P., Hattersley A. T., Walker M., Hitman G. A., et al. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat. Genet. 2005; 12: 1320–1322
   Web of Science ®Google Scholar